Citations (226)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Aleksandra Hedström, Marika Kvarnström, Greger Lindberg, Sandra Alsabeah, Hanna Alsabeah, Nelson Ndegwa, J. Matthias Löhr, Stephan L. Haas & Miroslav Vujasinovic. (2022) High prevalence of gastrointestinal symptoms in patients with primary Sjögren’s syndrome cannot be attributed to pancreatic exocrine insufficiency. Scandinavian Journal of Gastroenterology 57:10, pages 1250-1256.
Read now
Read now
Hugo Wallén, Brjánn Ljótsson, Cecilia Svanborg, Sara Rydh, Lisa Falk & Perjohan Lindfors. (2022) Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic – a clinical effectiveness study. Scandinavian Journal of Gastroenterology 57:8, pages 904-911.
Read now
Read now
Susanna Walter, Michael P. Jones, Jenny Sjödahl, Henrik Stjernman, Henrik Hjortswang & Anna Andreasson. (2021) Measuring the impact of gastrointestinal inconvenience and symptoms on perceived health in the general population – validation of the Short Health Scale for gastrointestinal symptoms (SHS-GI). Scandinavian Journal of Gastroenterology 56:12, pages 1406-1413.
Read now
Read now
Frida van Megen, Gry I. Skodje, Marianne Stendahl, Marit B. Veierød, Knut E. A. Lundin & Christine Henriksen. (2021) High disease burden in treated celiac patients – a web-based survey. Scandinavian Journal of Gastroenterology 56:8, pages 882-888.
Read now
Read now
Jesper Lexner, Henrik Hjortswang, Rickard Ekesbo & Klas Sjöberg. (2021) Well-being and dietary adherence in patients with coeliac disease depending on follow-up. Scandinavian Journal of Gastroenterology 56:4, pages 382-390.
Read now
Read now
David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin & Pontus Karling. (2019) Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scandinavian Journal of Gastroenterology 54:2, pages 152-157.
Read now
Read now
Gry I. Skodje, Christine Henriksen, Trude Salte, Thea Drivenes, Ieva Toleikyte, Astrid M. Lovik, Marit B. Veierød & Knut E.A. Lundin. (2017) Wheat challenge in self-reported gluten sensitivity: a comparison of scoring methods. Scandinavian Journal of Gastroenterology 52:2, pages 185-192.
Read now
Read now
Petter Hære, Ole Høie, Tom Schulz, Irina Schönhardt, Melinda Raki & Knut E. A. Lundin. (2016) Long-term mucosal recovery and healing in celiac disease is the rule – not the exception. Scandinavian Journal of Gastroenterology 51:12, pages 1439-1446.
Read now
Read now
Katja Boersma, Brjánn Ljótsson, Hanna Edebol-Carlman, Martien Schrooten, Steven J. Linton & Robert J. Brummer. (2016) Exposure-based cognitive behavioral therapy for irritable bowel syndrome. A single-case experimental design across 13 subjects. Cognitive Behaviour Therapy 45:6, pages 415-430.
Read now
Read now
Luise Mølenberg Begtrup, Ove B Schaffalitzky de Muckadell, Jens Kjeldsen, René dePont Christensen & Dorte Ejg Jarbøl. (2013) Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 48:10, pages 1127-1135.
Read now
Read now
Ragnar K. Breckan, Anne Mette Asfeldt, Bjørn Straume, Jon Florholmen & Eyvind J. Paulssen. (2012) Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway. Scandinavian Journal of Gastroenterology 47:11, pages 1274-1282.
Read now
Read now
Margit Brottveit, Per Olav Vandvik, Slawomir Wojniusz, Astrid Løvik, Knut EA Lundin & Birgitte Boye. (2012) Absence of somatization in non-coeliac gluten sensitivity. Scandinavian Journal of Gastroenterology 47:7, pages 770-777.
Read now
Read now
Glenn R. Gibson, Robert J. Brummer, Erika Isolauri, Herbert Lochs, Lorenzo Morelli, Theo Ockhuizen, Ian R. Rowland, Jürgen Schrezenmeir, Catherine Stanton & Kristin Verbeke. (2011) The design of probiotic studies to substantiate health claims.. Gut Microbes 2:5, pages 299-305.
Read now
Read now
S. Kaur Gill, P. Nguyen & G. Koren. (2009) Adherence and tolerability of iron-containing prenatal multivitamins in pregnant women with pre-existing gastrointestinal conditions. Journal of Obstetrics and Gynaecology 29:7, pages 594-598.
Read now
Read now
Gisela Ringström, Hasse Abrahamsson, Hans Strid & Magnus Simrén. (2007) Why do subjects with irritable bowel syndrome seek health care for their symptoms?. Scandinavian Journal of Gastroenterology 42:10, pages 1194-1203.
Read now
Read now
Articles from other publishers (211)
Lori McLeod, Claire Ervin, Sheri E. Fehnel, Sonya Eremenco, Robyn T. Carson, Jennifer Hanlon & Stephen Joel Coons. (2024) Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study. Value in Health 27:5, pages 614-622.
Crossref
Crossref
Xiao Ma, Hui Huan, Chao Liu, Hong Hu & Tao Ren. (2024) Influence of ethnic origin on the clinical characteristics and intestinal flora of irritable bowel syndrome: a prospective study between Han and Tibetan patients. Frontiers in Medicine 11.
Crossref
Crossref
Aisling Colgan, Katie Digby, Tanefa Apekey, Iona Elborough‐Whitehouse, Leah Seamark, Olivia Radcliffe, Marianne Williams & Mary Hickson. (2023) A dietitian‐led low‐FODMAP diet webinar: a pre–post study evaluating its impact on symptoms of irritable bowel syndrome. Journal of Human Nutrition and Dietetics 37:2, pages 396-407.
Crossref
Crossref
Johanna T.W. Snijkers, Bjorn Winkens, Zsa Zsa R.M. Weerts, Lisa VorkZlatan Mujagic, Martine A.M. Hesselink, Carsten Leue, Joanna W. Kruimel, Jean W.M. Muris, Daisy M.A.E. JonkersAd A.M. MascleeDaniel Keszthelyi. (2024) Satisfaction With Life in IBS Is Associated With Psychological Burden Rather than Gastrointestinal Symptom Severity. American Journal of Gastroenterology 119:3, pages 512-520.
Crossref
Crossref
Dorian Kern, Embla Lindfors, Lisa Lalér, Airene Lindfors, Brjánn Ljótsson & Perjohan Lindfors. (2024) Ashtangayoga for irritable bowel syndrome in a primary care setting: A feasibility study. Neurogastroenterology & Motility 36:3.
Crossref
Crossref
Cristina Iribarren, Otto Savolainen, Maria Sapnara, Hans Törnblom, Magnus Simrén, Maria K. Magnusson & Lena Öhman. (2024) Temporal stability of fecal metabolomic profiles in irritable bowel syndrome. Neurogastroenterology & Motility 36:3.
Crossref
Crossref
Rachel L. Buckle, Lydia C. Brown & Imran Aziz. (2024) Randomized trial in postprandial functional dyspepsia: Reassurance and diagnostic explanation with or without traditional dietary advice. Neurogastroenterology & Motility 36:3.
Crossref
Crossref
Lucian Marinica Grando, Jonas Halfvarson & Michiel van Nieuwenhoven. (2024) Rectal Sensory and Compliance Testing: A Method Comparison Study between High-Resolution Anorectal Manometry and Barostat Investigations. Diagnostics 14:4, pages 351.
Crossref
Crossref
Silvia Cruchet, Sandra Hirsch, Diana Villa-López, Mucio Moreno-Portillo, Juan C. Palomo, Ana T. Abreu-Abreu, Juan M. Abdo-Francis, Carlos Jiménez-Gutiérrez, Martin Rojano, Gabriel López-Velázquez & Pedro Gutiérrez-Castrellón. (2024) Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial. Frontiers in Gastroenterology 2.
Crossref
Crossref
Rabia Topan, Lisa Vork, Heather Fitzke, Shraya Pandya, Daniel Keszthelyi, Jan Cornelis, Jason Ellis, Lukas Van Oudenhove, Maaike Van Den HouteQasim Aziz. (2024) Poor Subjective Sleep Quality Predicts Symptoms in Irritable Bowel Syndrome Using the Experience Sampling Method. American Journal of Gastroenterology 119:1, pages 155-164.
Crossref
Crossref
Polina Lukina, Ina Lervåg Andersen, Petter Tinbod Eggen, Patricia Gjertrud Mjønes, Elin Rønne, Nils Bolstad, Rolf Anton Klaasen, David J Warren, Rasmus Iversen, Kristian Hveem, Tomm Bernklev, Lars Petter Jelsness-Jørgensen, Lise Pedersen, Iris Jonkers, Pernilla Lagergren, Ludvig Magne Sollid, Knut Lundin & Eivind Ness-Jensen. (2024) Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients. BMJ Open 14:1, pages e077131.
Crossref
Crossref
Anne Mari Herfindal, Frida van Megen, Mari K. O. Gilde, Jørgen Valeur, Knut Rudi, Gry I. Skodje, Knut E. A. Lundin, Christine Henriksen & Siv Kjølsrud Bøhn. (2023) Effects of a low FODMAP diet on gut microbiota in individuals with treated coeliac disease having persistent gastrointestinal symptoms – a randomised controlled trial. British Journal of Nutrition 130:12, pages 2061-2075.
Crossref
Crossref
Junjian Tian, Ting Li, Jun Zhao, Da Li, Jingwen Sun, Zhigang Li & Rongxing Shi. (2023) Efficacy of different courses of acupuncture for diarrhea irritable bowel syndrome: A protocol for systematic review and meta-analysis. PLOS ONE 18:12, pages e0295077.
Crossref
Crossref
Nir Bar, Amel KaraaKatheryn KiserBraden KuoClaire Zar-Kessler. (2023) Gastrointestinal Sensory Neuropathy and Dysmotility in Fabry Disease: Presentations and Effect on Patient's Quality of Life. Clinical and Translational Gastroenterology 14:12, pages e00633.
Crossref
Crossref
Craig Patch, Alan J. Pearce, Mek Cheng, Ray Boyapati & J. Thomas Brenna. (2023) Bacillus Subtilis (BG01-4TM) Improves Self-Reported Symptoms for Constipation, Indigestion, and Dyspepsia: A Phase 1/2A Randomized Controlled Trial. Nutrients 15:21, pages 4490.
Crossref
Crossref
Eirini Dimidi, Alastair James McArthur, Rachel White, Kevin Whelan & Miranda C. E. Lomer. (2023) Optimizing educational methods for the low FODMAP diet in disorders of gut–brain interaction: A feasibility randomized controlled trial. Neurogastroenterology & Motility 35:10.
Crossref
Crossref
Julie A. Bardacke, Linda Yarrow & Sara K. Rosenkranz. (2023) The Long-Term Effects of a Low–Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Irritable Bowel Syndrome Management. Current Developments in Nutrition 7:10, pages 101997.
Crossref
Crossref
Yunyao Qu, Si Hong Park & David C. Dallas. (2023) Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study. Nutrients 15:19, pages 4174.
Crossref
Crossref
Komal Deepak Kumar, Bridie Appleby‐Gunnill & Kate Maslin. (2023) Nutritional practices and dietetic provision in the endometriosis population, with a focus on functional gut symptoms. Journal of Human Nutrition and Dietetics 36:4, pages 1529-1538.
Crossref
Crossref
Yi-Cheng Tai, Peng-Hsiang Liao, Valentina Leta, Chin-Hsien Lin & K Ray Chaudhuri. (2023) Irritable bowel syndrome based on Rome IV diagnostic criteria associates with non-motor symptoms of Parkinson's disease. Parkinsonism & Related Disorders 113, pages 105496.
Crossref
Crossref
Janet L. Cunningham, Gunnel Nordmark, David Fällmar, Simon Cervenka, Maike Gallwitz, Roland Säll, Peter T. Schmidt, Johan Rönnelid, Barbro Persson, Andreas Kindmark & Joachim Burman. (2023) Experiences in implementing immunopsychiatry in real life. Journal of Affective Disorders Reports 13, pages 100597.
Crossref
Crossref
Mancai Wang, Xiaofeng Xie, Songbo Zhao, Xiaojuan Ma, Zheyuan Wang & Youcheng Zhang. (2023) Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Immunology 14.
Crossref
Crossref
Frida van Megen, Maria Fossli, Gry I. Skodje, Monica H. Carlsen, Lene F. Andersen, Marit B. Veierød, Knut E.A. Lundin & Christine Henriksen. (2023) Nutritional assessment of women with celiac disease compared to the general population. Clinical Nutrition ESPEN 54, pages 251-257.
Crossref
Crossref
Giuseppe Riezzo, Laura Prospero, Antonella Orlando, Michele Linsalata, Benedetta D’Attoma, Antonia Ignazzi, Gianluigi Giannelli & Francesco Russo. (2023) A Tritordeum-Based Diet for Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Effects on Abdominal Bloating and Psychological Symptoms. Nutrients 15:6, pages 1361.
Crossref
Crossref
Esther van Barneveld, Arianne Lim, Nehalennia van Hanegem, Frits van Osch, Lisa Vork, Joanna Kruimel, Marlies Bongers & Carsten Leue. (2023) Real-time Symptom Assessment in Patients With Endometriosis: Psychometric Evaluation of an Electronic Patient-Reported Outcome Measure, Based on the Experience Sampling Method. JMIR Formative Research 7, pages e29480.
Crossref
Crossref
Joost P. Algera, Esther Colomier, Chloé Melchior, Jóhann P. Hreinsson, Irina Midenfjord, Egbert Clevers, Magnus Simrén & Hans Törnblom. (2022) Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome. Neurogastroenterology & Motility 35:2.
Crossref
Crossref
Erland Axelsson & Erik Hedman-Lagerlöf. (2023) Validity and clinical utility of distinguishing between DSM-5 somatic symptom disorder and illness anxiety disorder in pathological health anxiety: Should we close the chapter?. Journal of Psychosomatic Research 165, pages 111133.
Crossref
Crossref
Michael Bach & Waltraud Bitterlich. (2023) Reizdarmsyndrom: psychosomatische AspekteIrritable Bowel Syndrome: Psychosomatic Aspects. psychopraxis. neuropraxis 26:1, pages 38-43.
Crossref
Crossref
Giorgia Gugelmo, Nicola Vitturi, Francesco Francini-Pesenti, Ilaria Fasan, Livia Lenzini, Romina Valentini, Gianni Carraro, Angelo Avogaro & Paolo Spinella. (2023) Gastrointestinal Manifestations and Low-FODMAP Protocol in a Cohort of Fabry Disease Adult Patients. Nutrients 15:3, pages 658.
Crossref
Crossref
Stefania Nicola, Francesco Cinetto, Stefano Della Mura, Luca Lo Sardo, Elena Saracco, Ilaria Vitali, Riccardo Scarpa, Helena Buso, Vera Bonato, Claudia Discardi, Giovanni Rolla, Carla Felice, Marcello Rattazzi & Luisa Brussino. (2023) The Importance of Endoscopy with Biopsy: Real-World Evidence of Gastrointestinal Involvement in Primary Immunodeficiency in Two Main Northern Italian Centres. Biomedicines 11:1, pages 170.
Crossref
Crossref
Linh M. Duong, Alice B. S. Nono Djotsa, Jacqueline Vahey, Lea Steele, Rachel Quaden, Kelly M. Harrington, Sarah T. Ahmed, Renato Polimanti, Elani Streja, John Michael Gaziano, John Concato, Hongyu Zhao, Krishnan Radhakrishnan, Elizabeth R. Hauser, Drew A. Helmer, Mihaela Aslan & Elizabeth J. Gifford. (2022) Association of Gulf War Illness with Characteristics in Deployed vs. Non-Deployed Gulf War Era Veterans in the Cooperative Studies Program 2006/Million Veteran Program 029 Cohort: A Cross-Sectional Analysis. International Journal of Environmental Research and Public Health 20:1, pages 258.
Crossref
Crossref
Olga Bednarska, Olga Biskou, Hans Israelsen, Martin E. Winberg, Susanna Walter & Åsa V. Keita. (2022) A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel syndrome. Frontiers in Nutrition 9.
Crossref
Crossref
Axel Josefsson, Hans Törnblom & Magnus Simrén. (2022) Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 28:4, pages 630-641.
Crossref
Crossref
Tessa R. Flood, Matthew R. Kuennen, Sam D. Blacker, Stephen D. Myers, Ella F. Walker & Ben J. Lee. (2022) The effect of sex, menstrual cycle phase and oral contraceptive use on intestinal permeability and ex-vivo monocyte TNFα release following treatment with lipopolysaccharide and hyperthermia. Cytokine 158, pages 155991.
Crossref
Crossref
Frida van Megen, Gry I. Skodje, Simon Lergenmuller, Stephanie Zühlke, Lars Aabakken, Marit B. Veierød, Christine Henriksen & Knut E.A. Lundin. (2022) A Low FODMAP Diet Reduces Symptoms in Treated Celiac Patients With Ongoing Symptoms–A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 20:10, pages 2258-2266.e3.
Crossref
Crossref
Martin L Kårhus, Andreas Brønden, Julie L Forman, Anne Haaber, Elisabeth Knudsen, Ebbe Langholz, Lars O Dragsted, Svend H Hansen, Martin Krakauer, Tina Vilsbøll, David P Sonne & Filip K Knop. (2022) Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial. The Lancet Gastroenterology & Hepatology 7:10, pages 922-931.
Crossref
Crossref
Chloé Melchior, Esther Colomier, Inês A. Trindade, Mahrukh Khadija, Jóhann P. Hreinsson, Hans Törnblom & Magnus Simrén. (2022) Irritable bowel syndrome: Factors of importance for disease‐specific quality of life. United European Gastroenterology Journal 10:7, pages 754-764.
Crossref
Crossref
Jessica E. Peters, Chamara Basnayake, Geoffrey S. Hebbard, Michael R. Salzberg & Michael A. Kamm. (2021) Prevalence of disordered eating in adults with gastrointestinal disorders: A systematic review. Neurogastroenterology & Motility 34:8.
Crossref
Crossref
Jessica R. Biesiekierski, Lauren P. Manning, Helen Burton Murray, Johan W. S. Vlaeyen, Brjánn Ljótsson & Lukas Van Oudenhove. (2022) Review article: exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 56:4, pages 592-605.
Crossref
Crossref
Inês A. Trindade, Chloé Melchior, Hans Törnblom & Magnus Simrén. (2022) Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling. Journal of Psychosomatic Research 159, pages 110809.
Crossref
Crossref
Alice S Day, Chu Kion Yao, Samuel P Costello, Andrew Ruszkiewicz, Jane M Andrews, Peter R Gibson & Robert V Bryant. (2022) Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study. The Journal of Nutrition 152:7, pages 1690-1701.
Crossref
Crossref
Hyunjung Kim, Younjae Oh & Sun Ju Chang. (2022) Internet-Delivered Cognitive Behavioral Therapy in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Journal of Medical Internet Research 24:6, pages e35260.
Crossref
Crossref
Jiahong Yang, Gina Ziruo Lin, Xiao Ying Li, Yu Tien Wang & Yet Hua Loh. (2021) Investigating the Role of Low-FODMAP Diet in Improving Gastrointestinal Symptoms in Irritable Bowel Syndrome. Proceedings of Singapore Healthcare 31, pages 201010582110514.
Crossref
Crossref
Michele Mun Hei Chan, Natalia Zarate‐Lopez & Lee Martin. (2021) Group education on the low FODMAP diet improves gastrointestinal symptoms but neither anxiety or depression in irritable bowel syndrome. Journal of Human Nutrition and Dietetics 35:3, pages 425-434.
Crossref
Crossref
Chloé Melchior, Joost Algera, Esther Colomier, Hans Törnblom, Magnus Simrén & Stine Störsrud. (2022) Food Avoidance and Restriction in Irritable Bowel Syndrome: Relevance for Symptoms, Quality of Life and Nutrient Intake. Clinical Gastroenterology and Hepatology 20:6, pages 1290-1298.e4.
Crossref
Crossref
Heidi M. Staudacher, Megan Rossi, Thomas Kaminski, Eirini Dimidi, Frances S. E. Ralph, Bridgette Wilson, Lee D. Martin, Petra Louis, Miranda C.E Lomer, Peter M. Irving & Kevin Whelan. (2021) Long‐term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterology & Motility 34:4.
Crossref
Crossref
David T. McNaughton, Anna Andreasson, Brjánn Ljótsson, Alissa P. Beath, Julia M. Hush, Gunnar Ljunggren, Peter T. Schmidt, Nicholas J. Talley, Lars Agréus & Michael P. Jones. (2021) Limited evidence of moderation of the association between gastrointestinal symptoms and prospective healthcare utilisation by quality of life. Alimentary Pharmacology & Therapeutics 55:3, pages 311-317.
Crossref
Crossref
Hana F. Zickgraf, Patrick Loftus, Benjamin Gibbons, Lauren C. Cohen & Melissa G. Hunt. (2022) “If I could survive without eating, it would be a huge relief”: Development and initial validation of the Fear of Food Questionnaire. Appetite 169, pages 105808.
Crossref
Crossref
Esther Colomier, Lukas Van Oudenhove, Jan Tack, Lena Böhn, Sean Bennet, Sanna Nybacka, Stine Störsrud, Lena Öhman, Hans Törnblom & Magnus Simrén. (2022) Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome. Nutrients 14:2, pages 397.
Crossref
Crossref
Sanna Nybacka, Hans Törnblom, Magnus Simren & Stine Störsrud. (2022) The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options. JMIR Research Protocols 11:1, pages e31413.
Crossref
Crossref
N.V. Bakulina, S.V. Tikhonov, E.I. Ermolenko, M.P. Kotyleva, N.S. Lavrenova, Yu.G. Topalova, V.I. Simanenkov & A.N. Suvorov. (2022) Intestinal microbiota, gastroenterological complaints and quality of life in overweight, obese and type 2 diabetes patients. Profilakticheskaya meditsina 25:6, pages 80.
Crossref
Crossref
Melissa G Hunt, Anika Dalvie, Simay Ipek & Ben Wasman. (2022) Acceptability and efficacy of the Zemedy app versus a relaxation training and meditation app for IBS: protocol for a randomised controlled trial. BMJ Open 12:1, pages e055014.
Crossref
Crossref
Elham Eslampour, Koroush Ghanadi, Vahideh Aghamohammadi, Alireza Moayed Kazemi, Rasool Mohammadi, Farhad Vahid & Amir Abbasnezhad. (2021) “Association between dietary inflammatory index (DII) and risk of irritable bowel syndrome: a case-control study”. Nutrition Journal 20:1.
Crossref
Crossref
Hugo Wallén, Perjohan Lindfors, Erik Andersson, Erik Hedman-Lagerlöf, Hugo Hesser, Nils Lindefors, Cecilia Svanborg & Brjánn Ljótsson. (2021) Return on investment of internet delivered exposure therapy for irritable bowel syndrome: a randomized controlled trial. BMC Gastroenterology 21:1.
Crossref
Crossref
Irina Midenfjord, Cecilia Grinsvall, Peter Koj, Ida Carnerup, Hans Törnblom & Magnus Simrén. (2021) Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease. Neurogastroenterology & Motility 33:12.
Crossref
Crossref
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld & T. Wedel. (2021) Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 59:12, pages 1323-1415.
Crossref
Crossref
Anupam Rej, Christian C. Shaw, Rachel L. Buckle, Nick Trott, Anurag Agrawal, Karen Mosey, Katie Sanders, Rupert Allen, Sophie Martin, Aimee Newton, Kelly Robinson, David Elphick, William D. Chey, Imran Aziz & David S. Sanders. (2021) The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up. Digestive and Liver Disease 53:11, pages 1404-1411.
Crossref
Crossref
Bridgette Wilson, Özge Eyice, Ioannis Koumoutsos, Miranda C. Lomer, Peter M. Irving, James O. Lindsay & Kevin Whelan. (2021) Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms. Nutrients 13:10, pages 3598.
Crossref
Crossref
Leah Seamark, Yvonne Barclay, Ceri Marchant, Marianne Williams & Mary Hickson. (2021) Long‐term symptom severity in people with irritable bowel syndrome following dietetic treatment in primary care: A service evaluation. Journal of Human Nutrition and Dietetics 34:5, pages 890-900.
Crossref
Crossref
Jacqueline Vahey, Elizabeth R. Hauser, Kellie J. Sims, Drew A. Helmer, Dawn Provenzale & Elizabeth J. Gifford. (2021) Research tool for classifying Gulf War illness using survey responses: Lessons for writing replicable algorithms for symptom-based conditions. Life Sciences 282, pages 119808.
Crossref
Crossref
Joost P. Algera, Stine Störsrud, Annika Lindström, Magnus Simrén & Hans Törnblom. (2021) Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study. Clinical Nutrition 40:10, pages 5365-5372.
Crossref
Crossref
Kia Nøhr Iversen, Frida Carlsson, Agneta Andersson, Karl Michaëlsson, Maud Langton, Ulf Risérus, Per M. Hellström & Rikard Landberg. (2021) A hypocaloric diet rich in high fiber rye foods causes greater reduction in body weight and body fat than a diet rich in refined wheat: A parallel randomized controlled trial in adults with overweight and obesity (the RyeWeight study). Clinical Nutrition ESPEN 45, pages 155-169.
Crossref
Crossref
Bettina Müller, Annica J. Rasmusson, David Just, Shishanthi Jayarathna, Ali Moazzami, Zorana Kurbalija Novicic & Janet L. Cunningham. (2021) Fecal Short-Chain Fatty Acid Ratios as Related to Gastrointestinal and Depressive Symptoms in Young Adults. Psychosomatic Medicine 83:7, pages 693-699.
Crossref
Crossref
I. B. Khlinov, R. I. Khlynova, E. I. Voronova, E. V. Garanina, I. A. Gurikova, T. I. Kobzar, M. E. Loseva, S. V. Odinets, O. A. Ryabinina, L. T. Sagutdinova & E. B. Freze. (2021) Efficacy and safety of Lactobacillus paracasei CNCM I-1572 and fructo- oligosaccharides in the treatment of patients with irritable bowel syndrome with constipation. Experimental and Clinical Gastroenterology 1:6, pages 57-62.
Crossref
Crossref
Hugo Hesser, Erik Hedman-Lagerlöf, Perjohan Lindfors, Erik Andersson & Brjánn Ljótsson. (2021) Behavioral avoidance moderates the effect of exposure therapy for irritable bowel syndrome: A secondary analysis of results from a randomized component trial. Behaviour Research and Therapy 141, pages 103862.
Crossref
Crossref
Melissa Hunt, Sofia Miguez, Benji Dukas, Obinna Onwude & Sarah White. (2021) Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial. JMIR mHealth and uHealth 9:5, pages e26152.
Crossref
Crossref
Irina Midenfjord, Adam Borg, Hans Törnblom & Magnus Simrén. (2021) Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome. American Journal of Gastroenterology 116:4, pages 769-779.
Crossref
Crossref
Cecilia Grinsvall, Hyo Jin Ryu, Lukas Van Oudenhove, Jennifer S. Labus, Arpana Gupta, Maria Ljungberg, Hans Törnblom, Emeran A. Mayer & Magnus Simrén. (2020) Association between pain sensitivity and gray matter properties in the sensorimotor network in women with irritable bowel syndrome. Neurogastroenterology & Motility 33:4.
Crossref
Crossref
Perjohan Lindfors, Erland Axelsson, Karin Engstrand, Stine Störsrud, Pernilla Jerlstad, Hans Törnblom, Brjánn Ljótsson, Magnus Simrén & Gisela Ringström. (2021) Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial. Clinical Gastroenterology and Hepatology 19:4, pages 743-751.e1.
Crossref
Crossref
Annikka Polster, Lena Öhman, Julien Tap, Muriel Derrien, Boris Le Nevé, Johanna Sundin, Hans Törnblom, Marija Cvijovic & Magnus Simrén. (2021) A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome. Scientific Reports 11:1.
Crossref
Crossref
Georgios Mavroudis, Hans Strid, Börje Jonefjäll & Magnus Simrén. (2020) Visceral hypersensitivity is together with psychological distress and female gender associated with severity of IBS‐like symptoms in quiescent ulcerative colitis. Neurogastroenterology & Motility 33:3.
Crossref
Crossref
Matthew Krouwel, Amanda Farley, Sheila Greenfield, Tariq Ismail & Kate Jolly. (2021) Systematic review, meta-analysis with subgroup analysis of hypnotherapy for irritable bowel syndrome, effect of intervention characteristics. Complementary Therapies in Medicine 57, pages 102672.
Crossref
Crossref
Chad Heatwole, Elizabeth LuebbeSpencer RoseroKaty EichingerWilliam MartensJames HilbertJeanne DekdebrunNuran DilekChristine ZizziNicholas JohnsonAraya PuwanantRabi TawilGiovanni SchifittoChristopher A. BeckJ. Franklin RichesonWojciech ZarebaCharles ThorntonMichael P. McDermottRichard MoxleyIIIIII. (2021) Mexiletine in Myotonic Dystrophy Type 1. Neurology 96:2.
Crossref
Crossref
Martin Aasbrenn, Stian Lydersen & Per G Farup. (2020) Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: a prospective cohort study. BMC Endocrine Disorders 20:1.
Crossref
Crossref
Fanny Söderquist, Mikaela Syk, David Just, Zorana Kurbalija Novicic, Annica J. Rasmusson, Per M. Hellström, Mia Ramklint & Janet L. Cunningham. (2020) A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults. BMC Psychiatry 20:1.
Crossref
Crossref
Cecilia Högberg, Pontus Karling, Jörgen Rutegård & Mikael Lilja. (2020) Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study. BMC Family Practice 21:1.
Crossref
Crossref
Cristina Iribarren, Hans Törnblom, Imran Aziz, Maria K. Magnusson, Johanna Sundin, Louise K. Vigsnæs, Ingvild Dybdrodt Amundsen, Bruce McConnell, Dorthe Seitzberg, Lena Öhman & Magnus Simrén. (2020) Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double‐blind, placebo‐controlled study. Neurogastroenterology & Motility 32:10.
Crossref
Crossref
Jenny Pagoldh, David Lundgren, Ole B Suhr & Pontus Karling. (2020) Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional study. Gastroenterology Report 8:5, pages 374-380.
Crossref
Crossref
Oddmund Nestegard, Kay-Martin Johnsen, Sveinung W. Sørbye, Fred-Arne Halvorsen, Tor Tønnessen, Eyvind J. Paulssen, Kjetil K. Melby, Rasmus Goll & Jon Florholmen. (2020) Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication. PLOS ONE 15:9, pages e0238944.
Crossref
Crossref
Birgitte Berentsen, Bharath Halandur Nagaraja, Erica Pearson Teige, Gülen Arslan Lied, Astri J. Lundervold, Katarina Lundervold, Elisabeth Kjelsvik Steinsvik, Eline Randulff Hillestad, Jørgen ValeurIngeborg Brønstad, Odd Helge Gilja, Berge Osnes, Jan Gunnar Hatlebakk, Judit Haász, Jennifer Labus, Arpana Gupta, Emeran A. Mayer, Alfonso Benitez-Páez, Yolanda Sanz, Arvid Lundervold & Trygve Hausken. (2020) Study protocol of the Bergen brain-gut-microbiota-axis study. Medicine 99:37, pages e21950.
Crossref
Crossref
Andrew T. Goldstein. 2020. Female Sexual Pain Disorders. Female Sexual Pain Disorders
115
124
.
Ran Yan, Mandy Murphy, Angela Genoni, Evania Marlow, Ian C Dunican, Johnny Lo, Lesley Andrew, Amanda Devine & Claus T Christophersen. (2020) Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial. BMJ Open Gastroenterology 7:1, pages e000448.
Crossref
Crossref
Irina Midenfjord, Annikka Polster, Henrik Sjövall, Peter Friberg, Hans Törnblom & Magnus Simrén. (2020) Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms. Scientific Reports 10:1.
Crossref
Crossref
Bridgette WilsonMegan RossiTokuwa KannoGareth C. ParkesSimon AndersonA. James MasonPeter M. IrvingMiranda C. LomerKevin Whelan. (2020) β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. American Journal of Gastroenterology 115:6, pages 906-915.
Crossref
Crossref
Luisa W Hugerth, Anna Andreasson, Nicholas J Talley, Anna M Forsberg, Lars Kjellström, Peter Thelin Schmidt, Lars Agreus & Lars Engstrand. (2020) No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut 69:6, pages 1076-1084.
Crossref
Crossref
Erland Axelsson, Maria Hedman-Lagerlöf, Erik Hedman-Lagerlöf, Brjánn Ljótsson & Erik Andersson. (2020) Symptom Preoccupation in Fibromyalgia: Prevalence and Correlates of Somatic Symptom Disorder in a Self-Recruited Sample. Psychosomatics 61:3, pages 268-276.
Crossref
Crossref
Philip D. Austin, Ali Asghari, Daniel S.J. Costa & Philip J. Siddall. (2020) The development of a novel questionnaire assessing alterations in central pain processing in people with and without chronic pain. Scandinavian Journal of Pain 20:2, pages 407-417.
Crossref
Crossref
Brjánn Ljótsson, Michael Jones, Nicholas J Talley, Lars Kjellström, Lars Agréus & Anna Andreasson. (2020) Discriminant and convergent validity of the GSRS‐IBS symptom severity measure for irritable bowel syndrome: A population study. United European Gastroenterology Journal 8:3, pages 284-292.
Crossref
Crossref
Morag Wright-McNaughtonSebastiaan ten Bokkel HuininkChristopher M.A. FramptonAndrew M. McCombieNicholas J. TalleyPaula M.L. SkidmoreRichard B. Gearry. (2019) Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary. Clinical and Translational Gastroenterology 10:12, pages e00103.
Crossref
Crossref
Stephanie Zühlke, Louise Fremgaard Risnes, Shiva Dahal-Koirala, Asbjørn Christophersen, Ludvig M Sollid & Knut EA Lundin. (2019) CD38 expression on gluten‐specific T cells is a robust marker of gluten re‐exposure in coeliac disease. United European Gastroenterology Journal 7:10, pages 1337-1344.
Crossref
Crossref
Johanna Sundin, Sofia Nordlander, Helene Eutamene, Valerie Alquier‐Bacquie, Christel Cartier, Vassilia Theodorou, Boris Le Nevé, Hans Törnblom, Magnus Simrén & Lena Öhman. (2019) Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome. Neurogastroenterology & Motility 31:11.
Crossref
Crossref
Ki-tae Kim. (2019) Two Case Reports of Patients with Diarrhea-predominant Irritable Bowel Syndrome Treated with Jeoreongchajeonja-tang. The Journal of Internal Korean Medicine 40:5, pages 948-956.
Crossref
Crossref
Petter Hære, Ole Høie, Knut E.A. Lundin & Glenn Haugeberg. (2019) No major reduction in bone mineral density after long-term treatment of patients with Celiac Disease. European Journal of Internal Medicine 68, pages 23-29.
Crossref
Crossref
Zsa Zsa R. M. Weerts, Lisa Vork, Zlatan Mujagic, Daniel Keszthelyi, Martine A. M. Hesselink, Joanna Kruimel, Carsten Leue, Jean W.M. Muris, Daisy M. A. E. Jonkers & Ad A. M. Masclee. (2019) Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome. Neurogastroenterology & Motility 31:8.
Crossref
Crossref
Irina Midenfjord, Annikka Polster, Henrik Sjövall, Hans Törnblom & Magnus Simrén. (2019) Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterology & Motility 31:8.
Crossref
Crossref
Magnus Simrén, Hans Törnblom, Olafur S. Palsson, Lukas Van Oudenhove, William E. Whitehead & Jan Tack. (2019) Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology 157:2, pages 391-402.e2.
Crossref
Crossref
Axel Josefsson, Amanda Rosendahl, Pernilla Jerlstad, Gunilla Näslin, Hans Törnblom & Magnus Simrén. (2019) Visceral sensitivity remains stable over time in patients with irritable bowel syndrome, but with individual fluctuations. Neurogastroenterology & Motility 31:7.
Crossref
Crossref
Janne Fassov, Lilli Lundby, Søren Laurberg & Klaus Krogh. (2019) Sacral nerve modulation for irritable bowel syndrome: A randomized, double‐blinded, placebo‐controlled crossover study. Neurogastroenterology & Motility 31:6.
Crossref
Crossref
Gry I. Skodje, Ingunn H. Minelle, Kjersti L. Rolfsen, Marina Iacovou, Knut E.A. Lundin, Marit B. Veierød & Christine Henriksen. (2019) Dietary and symptom assessment in adults with self-reported non-coeliac gluten sensitivity. Clinical Nutrition ESPEN 31, pages 88-94.
Crossref
Crossref
Michael E. Hyland, Alison M. Bacon, Joseph W. Lanario & Anthony F. Davies. (2019) Symptom frequency and development of a generic functional disorder symptom scale suitable for use in studies of patients with irritable bowel syndrome, fibromyalgia syndrome or chronic fatigue syndrome. Chronic Diseases and Translational Medicine 5:2, pages 129-138.
Crossref
Crossref
Savanne HolsterCarl Mårten LindqvistDirk RepsilberAnne SalonenWillem M. de VosJulia KönigRobert J. Brummer. (2019) The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study. Clinical and Translational Gastroenterology 10:4, pages e00034.
Crossref
Crossref
Hannah Mitchell, Judi Porter, Peter R. Gibson, Jacqueline Barrett & Mayur Garg. (2018) Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research. Alimentary Pharmacology & Therapeutics 49:2, pages 124-139.
Crossref
Crossref
Fanny Söderquist, Isak Sundberg, Mia Ramklint, Rebecka Widerström, Per M. Hellström & Janet L. Cunningham. (2019) The Relationship Between Daytime Salivary Melatonin and Gastrointestinal Symptoms in Young Adults Seeking Psychiatric Care. Psychosomatic Medicine 81:1, pages 51-56.
Crossref
Crossref
Anne Stine Kvehaugen & Per G. Farup. (2018) Changes in gastrointestinal symptoms and food tolerance 6 months following weight loss surgery: associations with dietary changes, weight loss and the surgical procedure. BMC Obesity 5:1.
Crossref
Crossref
Raphael Schiffmann, Daniel G. Bichet, Ana Jovanovic, Derralynn A. Hughes, Roberto Giugliani, Ulla Feldt-Rasmussen, Suma P. Shankar, Laura Barisoni, Robert B. Colvin, J. Charles Jennette, Fred Holdbrook, Andrew Mulberg, Jeffrey P. Castelli, Nina Skuban, Jay A. Barth & Kathleen Nicholls. (2018) Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Anne Stine Kvehaugen, Dag Tveiten & Per G. Farup. (2018) Is perceived intolerance to milk and wheat associated with the corresponding IgG and IgA food antibodies? A cross sectional study in subjects with morbid obesity and gastrointestinal symptoms. BMC Gastroenterology 18:1.
Crossref
Crossref
M. Connell, A. Shin, T. James‐Stevenson, H. Xu, T. F. Imperiale & J. Herron. (2018)
Systematic review and meta‐analysis: Efficacy of patented probiotic,
VSL
#3, in irritable bowel syndrome
. Neurogastroenterology & Motility 30:12.
Crossref
Crossref
Daniel Pohl, Lukas Van Oudenhove, Hans Törnblom, Boris Le Nevé, Jan Tack & Magnus Simrén. (2018) Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 16:11, pages 1745-1753.e1.
Crossref
Crossref
Jin Young Yoon, Jae Myung Cha, Ju Kyoung Oh, Pei Lei Tan, Sae Hun Kim, Min Seob Kwak, Jung Won Jeon & Hyun Phil Shin. (2018) Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study. Digestive Diseases and Sciences 63:10, pages 2754-2764.
Crossref
Crossref
Vikas K Sarna, Gry I Skodje, Henrik M Reims, Louise F Risnes, Shiva Dahal-Koirala, Ludvig M Sollid & Knut E A Lundin. (2018) HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge. Gut 67:9, pages 1606-1613.
Crossref
Crossref
Julia F. Henrich & Maryanne Martin. (2018) Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome. British Journal of Health Psychology 23:3, pages 612-629.
Crossref
Crossref
Egbert Clevers, Jan Tack, Hans Törnblom, Gisela Ringström, Koen Luyckx, Magnus Simrén & Lukas Van Oudenhove. (2018) Development of Irritable Bowel Syndrome Features Over a 5-year Period. Clinical Gastroenterology and Hepatology 16:8, pages 1244-1251.e1.
Crossref
Crossref
A. Polster, P. Friberg, V. Gunterberg, L. Öhman, B. Le Nevé, H. Törnblom, M. Cvijovic & M. Simren. (2018) Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms. Neurogastroenterology & Motility 30:7.
Crossref
Crossref
Marianne Bonnert, Ola Olén, Johan Bjureberg, Maria Lalouni, Erik Hedman-Lagerlöf, Eva Serlachius & Brjánn Ljótsson. (2018) The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis. Behaviour Research and Therapy 105, pages 27-35.
Crossref
Crossref
Julia F. Henrich, Bergljot Gjelsvik & Maryanne Martin. (2018) Implicit Identification with Illness in Patients with Irritable Bowel Syndrome (IBS). Cognitive Therapy and Research 42:3, pages 328-339.
Crossref
Crossref
Andrew T. Goldstein & Susan Kellogg Spadt. 2018. Textbook of Female Sexual Function and Dysfunction. Textbook of Female Sexual Function and Dysfunction
319
336
.
K. Whelan, L. D. Martin, H. M. Staudacher & M. C. E. Lomer. (2018)
The low
FODMAP
diet in the management of irritable bowel syndrome: an evidence‐based review of
FODMAP
restriction, reintroduction and personalisation in clinical practice
. Journal of Human Nutrition and Dietetics 31:2, pages 239-255.
Crossref
Crossref
Christopher V. Almario & Brennan M.R. Spiegel. (2018) Employing Irritable Bowel Syndrome Patient-Reported Outcomes in the Clinical Trenches. Clinical Gastroenterology and Hepatology 16:4, pages 462-466.e2.
Crossref
Crossref
L. Vork, D. Keszthelyi, Z. Mujagic, J. W. Kruimel, C. Leue, I. Pontén, H. Törnblom, M. Simrén, A. Albu‐Soda, Q. Aziz, M. Corsetti, L. Holvoet, J. Tack, S. S. Rao, J. van Os, E. G. Quetglas, D. A. Drossman & A. A. M. Masclee. (2017) Development, content validity, and cross‐cultural adaptation of a patient‐reported outcome measure for real‐time symptom assessment in irritable bowel syndrome. Neurogastroenterology & Motility 30:3.
Crossref
Crossref
Vikas K. Sarna, Knut E.A. Lundin, Lars Mørkrid, Shuo-Wang Qiao, Ludvig M. Sollid & Asbjørn Christophersen. (2018) HLA-DQ–Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption. Gastroenterology 154:4, pages 886-896.e6.
Crossref
Crossref
Magnus Simrén, Hans Törnblom, Olafur S Palsson, Miranda A L van Tilburg, Lukas Van Oudenhove, Jan Tack & William E Whitehead. (2018) Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut 67:2, pages 255-262.
Crossref
Crossref
Gry I. Skodje, Vikas K. Sarna, Ingunn H. Minelle, Kjersti L. Rolfsen, Jane G. Muir, Peter R. Gibson, Marit B. Veierød, Christine Henriksen & Knut E.A. Lundin. (2018) Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology 154:3, pages 529-539.e2.
Crossref
Crossref
Hong Yeol YooBoram ParkJungnam JooJung-Sup KimYumi LeeMyong Cheol LimDae Kyung Sohn, Sung-Bum KangKyu Joo Park. (2018) Validation of the Korean version of visual analogue scale for irritable bowel syndrome questionnaire for assessment of defecation pattern changes. Annals of Surgical Treatment and Research 94:5, pages 254.
Crossref
Crossref
Kyung Sik Park. (2018) What Is the Role of the Low FODMAP Diets in the Management of Irritable Bowel Syndrome?. The Korean Journal of Gastroenterology 71:2, pages 107.
Crossref
Crossref
Martin Aasbrenn, Stian Lydersen & Per G. Farup. (2018) A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study. Journal of Obesity 2018, pages 1-9.
Crossref
Crossref
M. O'Keeffe, C. Jansen, L. Martin, M. Williams, L. Seamark, H. M. Staudacher, P. M. Irving, K. Whelan & M. C. Lomer. (2017)
Long‐term impact of the low‐
FODMAP
diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome
. Neurogastroenterology & Motility 30:1.
Crossref
Crossref
Robert Winther, Martin Aasbrenn & Per G. Farup. (2017) Intake of non-nutritive sweeteners is associated with an unhealthy lifestyle: a cross-sectional study in subjects with morbid obesity. BMC Obesity 4:1.
Crossref
Crossref
Enzo Vicari, Michele Salemi, Giuseppe Sidoti, Mariano Malaguarnera & Roberto Castiglione. (2017) Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome. Nutrients 9:11, pages 1208.
Crossref
Crossref
Andrew Dainty, Melissa Hunt, Elizabeth Holtham, Philip Kinsella, Stephen Timmons, Mark Fox & Patrick Callaghan. (2017) The feasibility of nurse-delivered, low-intensity cognitive behavioural therapy for irritable bowel syndrome. Gastrointestinal Nursing 15:9, pages 39-49.
Crossref
Crossref
Sula Windgassen, Rona Moss‐Morris, Joseph Chilcot, Alice Sibelli, Kimberley Goldsmith & Trudie Chalder. (2017) The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. British Journal of Health Psychology 22:4, pages 701-736.
Crossref
Crossref
H. Hesser, E. Hedman, P. Lindfors, E. Andersson & B. Ljótsson. (2017) The specific effect of systematic exposure in irritable bowel syndrome: complier average causal effect analysis using growth mixture modeling. Psychological Medicine 47:15, pages 2653-2662.
Crossref
Crossref
Heidi Maria Staudacher, Miranda C.E. Lomer, Freda M. Farquharson, Petra Louis, Francesca Fava, Elena Franciosi, Matthias Scholz, Kieran M. Tuohy, James O. Lindsay, Peter M. Irving & Kevin Whelan. (2017) A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial. Gastroenterology 153:4, pages 936-947.
Crossref
Crossref
Wathsala Nanayakkara, Richard Gearry, Jane Muir, Leigh O’Brien, Tim Wilkinson, Jonathan Williman & Paula Skidmore. (2017) Gastrointestinal Symptoms and FODMAP Intake of Aged-Care Residents from Christchurch, New Zealand. Nutrients 9:10, pages 1083.
Crossref
Crossref
A. Polster, L. Van Oudenhove, M. Jones, L. Öhman, H. Törnblom & M. Simrén. (2017) Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms. Alimentary Pharmacology & Therapeutics 46:5, pages 529-539.
Crossref
Crossref
Wendy A. Henderson, Bridgett Rahim-Williams, Kevin H. Kim, LeeAnne B. Sherwin, Sarah K. Abey, Angela C. Martino, Nicolaas H. Fourie, Margaret M. Heitkemper & Anthony P. Zuccolotto. (2017) The Gastrointestinal Pain Pointer. Gastroenterology Nursing 40:5, pages 357-363.
Crossref
Crossref
Aelee Jang, Sun-Kyung Hwang, Nikhil S Padhye & Janet C Meininger. (2017) Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial. Journal of Neurogastroenterology and Motility 23:3, pages 435-445.
Crossref
Crossref
J. Fassov, L. Lundby, S. Laurberg, S. Buntzen & K. Krogh. (2017) Three‐year follow‐up of sacral nerve stimulation for patients with diarrhoea‐predominant and mixed irritable bowel syndrome. Colorectal Disease 19:2, pages 188-193.
Crossref
Crossref
Piero Porcelli, Massimo De Carne & Gioacchino Leandro. (2017) The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome. Comprehensive Psychiatry 73, pages 127-135.
Crossref
Crossref
Marianne Bonnert, Ola Olén, Maria Lalouni, Marc A Benninga, Matteo Bottai, Johanna Engelbrektsson, Erik Hedman, Fabian Lenhard, Bo Melin, Magnus Simrén, Sarah Vigerland, Eva Serlachius & Brjánn Ljótsson. (2017) Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial. American Journal of Gastroenterology 112:1, pages 152-162.
Crossref
Crossref
Marianne Williams, Yvonne Barclay, Rosie Benneyworth, Steve Gore, Zoe Hamilton, Rudi Matull, Iain Phillips, Leah Seamark, Kate Staveley, Steve Thole & Emma Greig. (2016) Using best practice to create a pathway to improve management of irritable bowel syndrome: aiming for timely diagnosis, effective treatment and equitable care. Frontline Gastroenterology 7:4, pages 323-330.
Crossref
Crossref
N. Kanuri, B. Cassell, S. E. Bruce, K. S. White, B. M. Gott, C. P. Gyawali & G. S. Sayuk. (2016)
The impact of abuse and mood on bowel symptoms and health‐related quality of life in irritable bowel syndrome (
IBS
)
. Neurogastroenterology & Motility 28:10, pages 1508-1517.
Crossref
Crossref
Silje F Jørgensen, Henrik M Reims, Didrik Frydenlund, Kristian Holm, Vemund Paulsen, Annika E Michelsen, Kristin K Jørgensen, Liv T Osnes, Jorunn Bratlie, Tor J Eide, Christen P Dahl, Ellen Holter, Rune R Tronstad, Kurt Hanevik, Hans-Richard Brattbakk, Fatemeh Kaveh, Torunn Fiskerstrand, Anne-Marte B Kran, Thor Ueland, Tom H Karlsen, Pål Aukrust, Knut E A Lundin & Børre Fevang. (2016) A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency. American Journal of Gastroenterology 111:10, pages 1467-1475.
Crossref
Crossref
G. E. Boeckxstaens, V. Drug, D. Dumitrascu, A. D. Farmer, J. Hammer, T. Hausken, B. Niesler, D. Pohl, L. Pojskic, A. Polster, M. Simren, M. Goebel‐Stengel, L. Van Oudenhove, M. Vassallo, K.‐A. Wensaas, Q. Aziz & L. A. Houghton. (2016)
Phenotyping of subjects for large scale studies on patients with
IBS
. Neurogastroenterology & Motility 28:8, pages 1134-1147.
Crossref
Crossref
Pontus Karling, Mikael Wikgren, Rolf Adolfsson & Karl-Fredrik Norrback. (2016) Hypothalamus-Pituitary-Adrenal Axis Hypersuppression Is Associated with Gastrointestinal Symptoms in Major Depression. Journal of Neurogastroenterology and Motility 22:2, pages 292-303.
Crossref
Crossref
L. Neri & P. Iovino. (2016) Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation‐predominant irritable bowel syndrome and functional constipation. Neurogastroenterology & Motility 28:4, pages 581-591.
Crossref
Crossref
Jakob Duelund-Jakobsen, Paul-Antoine Lehur, Lilli Lundby, Vincent Wyart, S?ren Laurberg & Steen Buntzen. (2015) Sacral nerve stimulation for faecal incontinence?efficacy confirmed from a two-centre prospectively maintained database. International Journal of Colorectal Disease 31:2, pages 421-428.
Crossref
Crossref
Pontus Karling, Martin Maripuu, Mikael Wikgren, Rolf Adolfsson & Karl-Fredrik Norrback. (2016) Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder. World Journal of Gastroenterology 22:38, pages 8540.
Crossref
Crossref
L. S. Tipsmark, J. Fassov, L. Lundby, S. Laurberg, L. Ehlers & K. Krogh. (2016) Cost‐effectiveness analysis of sacral nerve stimulation as treatment for severe irritable bowel syndrome. Colorectal Disease 18:1.
Crossref
Crossref
Jessica A. Briscoe & Sandra M. Quezada. 2016. Telemanagement of Inflammatory Bowel Disease. Telemanagement of Inflammatory Bowel Disease
19
34
.
C. Grinsvall, H. Törnblom, J. Tack, L. Van Oudenhove & M. Simrén. (2015) Psychological factors selectively upregulate rectal pain perception in hypersensitive patients with irritable bowel syndrome. Neurogastroenterology & Motility 27:12, pages 1772-1782.
Crossref
Crossref
J. Duelund‐Jakobsen, S. Buntzen, L. Lundby, M. Sørensen & S. Laurberg. (2015) Bilateral compared with unilateral sacral nerve stimulation for faecal incontinence: results of a randomized, single‐blinded crossover study. Colorectal Disease 17:12, pages 1085-1093.
Crossref
Crossref
M. Mego, A. Accarino, J.‐R. Malagelada, F. Guarner & F. Azpiroz. (2015) Accumulative effect of food residues on intestinal gas production. Neurogastroenterology & Motility 27:11, pages 1621-1628.
Crossref
Crossref
Z. Mujagic, D. Keszthelyi, Q. Aziz, W. Reinisch, E. G. Quetglas, F. De Leonardis, M. Segerdahl & A. A. M. Masclee. (2015) Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 42:9, pages 1064-1081.
Crossref
Crossref
Gregor Liegl, Constantin Y. Plessen, Anton Leitner, Markus Boeckle & Christoph Pieh. (2015) Guided self-help interventions for irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 27:10, pages 1209-1221.
Crossref
Crossref
Naoyoshi Nagata, Ryota Niikura, Tomonori Aoki, Takuro Shimbo, Katsunori Sekine, Hidetaka Okubo, Kazuhiro Watanabe, Toshiyuki Sakurai, Chizu Yokoi, Mikio Yanase, Junichi Akiyama & Naomi Uemura. (2015)
Association between colonic diverticulosis and bowel symptoms: A case‐control study of 1629
A
sian patients
. Journal of Gastroenterology and Hepatology 30:8, pages 1252-1259.
Crossref
Crossref
Göran Lind, Jaleh Winter, Bengt Linderoth & Per M. Hellström. (2015) Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 308:10, pages R887-R894.
Crossref
Crossref
Naoyoshi Nagata, Kayo Sakamoto, Tomohiro Arai, Ryota Niikura, Takuro Shimbo, Masafumi Shinozaki, Noriko Ihana, Katsunori Sekine, Hidetaka Okubo, Kazuhiro Watanabe, Toshiyuki Sakurai, Chizu Yokoi, Mikio Yanase, Junichi Akiyama, Naomi Uemura & Mitsuhiko Noda. (2015) Effect of Body Mass Index and Intra-Abdominal Fat Measured by Computed Tomography on the Risk of Bowel Symptoms. PLOS ONE 10:4, pages e0123993.
Crossref
Crossref
Melissa G. Hunt, Elisabeth Ertel, Jordan A. Coello & Lauren Rodriguez. (2014) Empirical Support for a Self-help Treatment for IBS. Cognitive Therapy and Research 39:2, pages 215-227.
Crossref
Crossref
Antal Bajor, Hans Törnblom, Mats Rudling, Kjell-Arne Ung & Magnus Simrén. (2015) Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut 64:1, pages 84-92.
Crossref
Crossref
Naoyoshi Nagata, Ryota Niikura, Tomonori Aoki, Takuro Shimbo, Yoshihiro Kishida, Katsunori Sekine, Shohei Tanaka, Hidetaka Okubo, Kazuhiro Watanabe, Toshiyuki Sakurai, Chizu Yokoi, Junichi Akiyama, Mikio Yanase, Masashi Mizokami & Naomi Uemura. (2014) Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy. Gastrointestinal Endoscopy 80:6, pages 1124-1131.
Crossref
Crossref
J. Fassov, C. Brock, L. Lundby, A. M. Drewes, H. Gregersen, S. Buntzen, S. Laurberg & K. Krogh. (2014) Sacral nerve stimulation changes rectal sensitivity and biomechanical properties in patients with irritable bowel syndrome. Neurogastroenterology & Motility 26:11, pages 1597-1604.
Crossref
Crossref
Klara Garsed, Julia Chernova, Margaret Hastings, Ching Lam, Luca Marciani, Gulzar Singh, Amanda Henry, Ian Hall, Peter Whorwell & Robin Spiller. (2014) A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut 63:10, pages 1617-1625.
Crossref
Crossref
Naoyoshi Nagata, Ryota Niikura, Tomonori Aoki, Takuro Shimbo, Yoshihiro Kishida, Katsunori Sekine, Shohei Tanaka, Kazuhiro Watanabe, Toshiyuki Sakurai, Chizu Yokoi, Junichi Akiyama, Mikio Yanase, Masashi Mizokami & Naomi Uemura. (2014) Colonic diverticular hemorrhage associated with the use of nonsteroidal anti‐inflammatory drugs, low‐dose aspirin, antiplatelet drugs, and dual therapy. Journal of Gastroenterology and Hepatology 29:10, pages 1786-1793.
Crossref
Crossref
Piero Porcelli, Massimo De Carne & Gioacchino Leandro. (2014) Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome. Comprehensive Psychiatry 55:7, pages 1647-1653.
Crossref
Crossref
J. Vu, V. Kushnir, B. Cassell, C. P. Gyawali & G. S. Sayuk. (2014)
The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional
GI
disorders
. Neurogastroenterology & Motility 26:9, pages 1323-1332.
Crossref
Crossref
Melissa G. Hunt, Elisabeth Ertel, Jordan A. Coello & Lauren Rodriguez. (2014) Development and Validation of the GI-Cognitions Questionnaire. Cognitive Therapy and Research 38:4, pages 472-482.
Crossref
Crossref
Janne L. Fassov, Lilli Lundby, Søren Laurberg, Steen Buntzen & Klaus Krogh. (2014) A Randomized, Controlled, Crossover Study of Sacral Nerve Stimulation for Irritable Bowel Syndrome. Annals of Surgery 260:1, pages 31-36.
Crossref
Crossref
Li Li, Lishou Xiong, Shenghong Zhang, Qiao Yu & Minhu Chen. (2014) Cognitive–behavioral therapy for irritable bowel syndrome: A meta-analysis. Journal of Psychosomatic Research 77:1, pages 1-12.
Crossref
Crossref
Marianne Bonnert, Brjánn Ljótsson, Erik Hedman, Johanna Andersson, Henrik Arnell, Marc A. Benninga, Magnus Simrén, Helena Thulin, Ulrika Thulin, Sarah Vigerland, Eva Serlachius & Ola Olén. (2014) Internet-delivered cognitive behavior therapy for adolescents with functional gastrointestinal disorders — An open trial. Internet Interventions 1:3, pages 141-148.
Crossref
Crossref
A. D. Dainty, M. Fox, N. Lewis, M. Hunt, E. Holtham, S. Timmons, P. Kinsella, A. Wragg & P. Callaghan. (2014) A mixed methods feasibility study to evaluate the use of a low-intensity, nurse-delivered cognitive behavioural therapy for the treatment of irritable bowel syndrome. BMJ Open 4:6, pages e005262-e005262.
Crossref
Crossref
P Marquis, K E Lasch, L Delgado-Herrera, S Kothari, A Lembo, C Lademacher, G Spears, A Nishida, Waldman L Tesler, E Piault, K Rosa & B Zeiher. (2014) Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 5:6, pages e59.
Crossref
Crossref
Brjánn Ljótsson, Hugo Hesser, Erik Andersson, Jeffrey M. Lackner, Samir El Alaoui, Lisa Falk, Kristina Aspvall, Josefin Fransson, Klara Hammarlund, Anna Löfström, Sanna Nowinski, Perjohan Lindfors & Erik Hedman. (2014) Provoking symptoms to relieve symptoms: A randomized controlled dismantling study of exposure therapy in irritable bowel syndrome. Behaviour Research and Therapy 55, pages 27-39.
Crossref
Crossref
Puja Khanna, Nikhil Agarwal, Dinesh Khanna, Ron D Hays, Lin Chang, Roger Bolus, Gil Melmed, Cynthia B Whitman, Robert M Kaplan, Rikke Ogawa, Bradley Snyder & Brennan MR Spiegel. (2014) Development of an Online Library of Patient-Reported Outcome Measures in Gastroenterology: The GI-PRO Database. American Journal of Gastroenterology 109:2, pages 234-248.
Crossref
Crossref
Jin Young YoonSoo Jung ParkJae Hee Cheon. (2014) Effect of Colostrum on the Symptoms and Mucosal Permeability in Patients with Irritable Bowel Syndrome: A Randomized Placebo-controlled Study. Intestinal Research 12:1, pages 80.
Crossref
Crossref
Paola Iovino. (2014) Bloating and functional gastro-intestinal disorders: Where are we and where are we going?. World Journal of Gastroenterology 20:39, pages 14407.
Crossref
Crossref
Brjánn Ljótsson, Erik Andersson, Perjohan Lindfors, Jeffrey M Lackner, Karin Grönberg, Katarina Molin, Johanna Norén, Karin Romberg, Evelyn Andersson, Timo Hursti, Hugo Hesser & Erik Hedman. (2013) Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome. BMC Gastroenterology 13:1.
Crossref
Crossref
Magnus Simrén & Hans TörnblomEleni Athanasakos & Anton Emmanuel. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
171
193
.
Khaled Al-shair, Graham T.W. Atherton, Deborah Kennedy, Georgina Powell, David W. Denning & Ann Caress. (2013) Validity and Reliability of the St. George's Respiratory Questionnaire in Assessing Health Status in Patients With Chronic Pulmonary Aspergillosis. Chest 144:2, pages 623-631.
Crossref
Crossref
Luise M. Begtrup, Anne Line Engsbro, Jens Kjeldsen, Pia V. Larsen, Ove Schaffalitzky de Muckadell, Peter Bytzer & Dorte E. Jarbøl. (2013) A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 11:8, pages 956-962.e1.
Crossref
Crossref
Anne Line Engsbro, Luise Mølenberg Begtrup, Jens Kjeldsen, Pia Veldt Larsen, Ove Schaffalitzky de Muckadell, Dorte Ejg Jarbøl & Peter Bytzer. (2013) Patients Suspected of Irritable Bowel Syndrome—Cross-Sectional Study Exploring the Sensitivity of Rome III Criteria in Primary Care. American Journal of Gastroenterology 108:6, pages 972-980.
Crossref
Crossref
Hans Törnblom & Magnus Simrén. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome
277
299
.
Margit Brottveit, Ann-Christin R Beitnes, Stig Tollefsen, Jorunn E Bratlie, Frode L Jahnsen, Finn-Eirik Johansen, Ludvig M Sollid & Knut E A Lundin. (2013) Mucosal Cytokine Response After Short-Term Gluten Challenge in Celiac Disease and Non-Celiac Gluten Sensitivity. American Journal of Gastroenterology 108:5, pages 842-850.
Crossref
Crossref
Brennan M R Spiegel. (2013) Patient-Reported Outcomes in Gastroenterology: Clinical and Research Applications. Journal of Neurogastroenterology and Motility 19:2, pages 137-148.
Crossref
Crossref
J. Labus, A. Gupta, H. K. Gill, I. Posserud, M. Mayer, H. Raeen, R. Bolus, M. Simren, B. D. Naliboff & E. A. Mayer. (2012) Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho‐education group intervention. Alimentary Pharmacology & Therapeutics 37:3, pages 304-315.
Crossref
Crossref
Jakob Duelund-Jakobsen, Steen Buntzen, Lilli Lundby & Søren Laurberg. (2013) Sacral Nerve Stimulation at Subsensory Threshold Does Not Compromise Treatment Efficacy. Annals of Surgery 257:2, pages 219-223.
Crossref
Crossref
Displaying 200 of 226 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list